ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma

免疫疗法 嵌合抗原受体 癌症研究 医学 头颈部鳞状细胞癌 癌症 靶向治疗 T细胞 肿瘤微环境 抗原 免疫系统 免疫学 肿瘤科 头颈部癌 内科学
作者
Saffron E. Summers,Vehid Salih,Andrew Foey
出处
期刊:Frontiers in dental medicine [Frontiers Media]
卷期号:4 被引量:1
标识
DOI:10.3389/fdmed.2023.1116402
摘要

Chimeric antigen receptor T (CAR-T) cell therapy has shown great success in treating B cell malignancies; however, there are many challenges that limit their therapeutic efficacy in solid tumours. Immunotherapy of head and neck squamous cell carcinoma (HNSCC), and, in particular, oral squamous cell carcinoma (OSCC), presents a unique set of challenges including lack of consistently expressed tumour associated antigens (TAAs) and the immunosuppressive tumour microenvironment (TME). Currently, there are few clinical trials investigating the use of CAR-T cells in HNSCC/OSCC; however, results from trials investigating similar solid tumours, such as breast cancer, can be adopted to help evaluate the use of CAR-T in this cancer. In this review, the process of CAR-T cell engineering and different generations of these cells will be summarised, highlighting their potential use in treating HNSCC through targeting ErbB and MUC1; TAAs highly expressed by this solid tumour. Potential strategies including combination therapy, utilising both TAA-targeting CAR-Ts and immune checkpoint inhibitors, such as PD-L1, have been discussed, in an attempt to develop synergistic anti-tumour responses. In addition to this, the use of dual-targeting CAR-T cells, synthetic NOTCH (synNOTCH) receptors and alternative non-tumour targets of the TME have been reviewed. Such combination therapies have been shown to help limit solid tumour progression and enhance both the safety and efficacy of CAR-T cell immunotherapy, which may be adopted for the treatment and management of OSCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
丘比特应助科研通管家采纳,获得10
1秒前
猪猪hero应助科研通管家采纳,获得10
1秒前
上官若男应助科研通管家采纳,获得10
1秒前
科目三应助科研通管家采纳,获得10
2秒前
猪猪hero应助科研通管家采纳,获得10
2秒前
坦率的匪应助科研通管家采纳,获得10
2秒前
星夜发布了新的文献求助10
2秒前
丘比特应助科研通管家采纳,获得10
2秒前
2秒前
田様应助科研通管家采纳,获得10
2秒前
在水一方应助科研通管家采纳,获得10
2秒前
CipherSage应助科研通管家采纳,获得10
2秒前
桐桐应助科研通管家采纳,获得10
3秒前
爆米花应助科研通管家采纳,获得10
3秒前
坦率的匪应助科研通管家采纳,获得10
3秒前
深情安青应助科研通管家采纳,获得10
3秒前
赘婿应助科研通管家采纳,获得10
3秒前
我是老大应助科研通管家采纳,获得10
3秒前
坦率的匪应助科研通管家采纳,获得10
3秒前
3秒前
共享精神应助科研通管家采纳,获得10
3秒前
坦率的匪应助科研通管家采纳,获得10
3秒前
duohao2023应助科研通管家采纳,获得10
3秒前
4秒前
猪猪hero应助科研通管家采纳,获得10
4秒前
猪猪hero应助科研通管家采纳,获得10
4秒前
recovery应助科研通管家采纳,获得10
4秒前
uniquellll完成签到,获得积分10
4秒前
我是老大应助科研通管家采纳,获得10
4秒前
4秒前
日富一日完成签到 ,获得积分10
5秒前
阳光水壶发布了新的文献求助10
5秒前
斯可完成签到,获得积分10
6秒前
英俊的铭应助Zyy采纳,获得10
6秒前
本凡完成签到,获得积分10
7秒前
8秒前
过时的茗茗完成签到 ,获得积分10
10秒前
大模型应助aha采纳,获得10
11秒前
12秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988838
求助须知:如何正确求助?哪些是违规求助? 3531250
关于积分的说明 11252914
捐赠科研通 3269838
什么是DOI,文献DOI怎么找? 1804820
邀请新用户注册赠送积分活动 881943
科研通“疑难数据库(出版商)”最低求助积分说明 809028